LiverMultiScan Analysis of MRI Scans in HCC
NCT04451603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2024-03-13
Summary
This project is a pilot study to interrogate the potential of LMS as a predictive tool for the selection of therapy for HCC patients. The reliability of LMS to predict patients' response following HCC therapy will leverage on an algorithm that is built from the pool of MRI scans from HCC patients pre- and post-treatment. In the study, MRI scans of 30 HCC and metastatic colorectal cancer (CM) patients (ratio of 4:1) will be analysed. CM cancer patients include patients whose cancers metastasized from colorectal cancer or primary liver cancer. These patients will either receive one of the treatment, surgical resection, Y90 or systemic therapy. A total of 4 MRI scans will be taken for each patient; the first MRI scan will be taken within a month before treatment initiation and the remaining MRI scans will be taken at the 1st, 3rd and 9th month post-initiation of treatment.
Conditions
Interventions
- PROCEDURE
-
Surgery
Surgical resection of the liver
- RADIATION
-
Radiation therapy
Y-90 radioembolization therapy is the main treatment
- DRUG
-
Drug treatment
Examples include tyrosine kinase inhibitors and immune checkpoint inhibitors
Sponsors & Collaborators
-
Perspectum
collaborator INDUSTRY -
National Cancer Centre, Singapore
lead OTHER
Principal Investigators
-
Pierce Chow · National Cancer Centre, Singapore
Eligibility
- Min Age
- 21 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-19
- Primary Completion
- 2021-03-16
- Completion
- 2023-12-31
Countries
- Singapore
Study Locations
More Related Trials
-
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
NCT06096896 ·Status: ACTIVE_NOT_RECRUITING
-
The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma
NCT05573217 ·Status: UNKNOWN
-
Prospective Liver Study
NCT01539993 ·Status: COMPLETED
-
Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma
NCT02725073 ·Status: UNKNOWN ·Phase: PHASE2
-
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NCT05444478 ·Status: RECRUITING ·Phase: NA
-
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
NCT03668158 ·Status: UNKNOWN
-
A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer
NCT05371873 ·Status: UNKNOWN
-
Protein Biomarker in Hepatocellular Carcinoma
NCT00465842 ·Status: TERMINATED
-
Lenvatinib Therapy in HCC Patients After LDLT
NCT05572528 ·Status: RECRUITING
-
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment
NCT04143516 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm
NCT01825824 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Cohort Study of Liver Cancer Patients Treated With Proton Beam Therapy
NCT04466124 ·Status: ENROLLING_BY_INVITATION
-
Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer
NCT05160740 ·Status: RECRUITING ·Phase: NA
-
Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT
NCT06408753 ·Status: COMPLETED
-
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
NCT01668134 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma
NCT06086002 ·Status: COMPLETED ·Phase: NA
-
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
NCT06478693 ·Status: RECRUITING ·Phase: PHASE1
-
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
NCT06746194 ·Status: RECRUITING
-
Recurrent Liver Cancer: Reconceptualization and Reevaluation
NCT06430983 ·Status: RECRUITING
-
Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis
NCT02309788 ·Status: UNKNOWN
-
Relationship Between Microbiota and Prognosis of Hepatocellular Carcinoma(HCC) After Systemic Treatments
NCT05443217 ·Status: UNKNOWN
-
The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene
NCT01786980 ·Status: COMPLETED
-
Quality of Life in Patients With Hepatocellular Carcinoma
NCT02420678 ·Status: UNKNOWN
-
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
NCT01850667 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy
NCT00482586 ·Status: COMPLETED